This federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, is for the provision of CEPHEID REAGENT XPERT MRSA, FLU, & COVID TEST KITS. The contract, awarded by the Veterans Integrated Service Network 21 (VISN 21), a component of the Department of Veterans Affairs (VA), has a ceiling value of $653,649.60 and a period of performance through January 31, 2026. This appears to be a delivery order under a larger indefinite delivery vehicle (IDV) contract between Cepheid and VISN 21 for the procurement of Cepheid's molecular diagnostic test kits compatible with the VA's existing GeneXpert analyzers. The contract does not have a set-aside designation. This award allows the VA to continuously procure Cepheid's diagnostic solutions to support clinical testing programs serving veterans.
Generated 2/4/25, 10:34 AM